One should expect bleeding as a consequence of PS cloaking. It's also reasonable to assume that a balance has been established in regards to administered dosage, and expected physiological tissue injury, thus the 1mg/3mg dosing.
If one is going to argue invalidity, and use terms such as, placebo, then isn't it oxymoronic to then challenge others with Bavituximab AE's? Just saying...
Also, I would suspect that the following quote has been proven, and established among human physiology teaching. Would anyone disagree?
"Phosphatidylserine enhances the activation of prothrombin to thrombin (the key molecule in the blood clotting cascade)"
All the best,
John
Market Data 
Markets 
AI
